Rating Change
UBS analysts reiterated a Neutral rating on The Clorox Company (NYSE:CLX) on August 04, 2026.
reiterateNYSE:CLX
UBS Reiterates Neutral Rating on The Clorox Company (CLX)
Rating Change UBS analysts reiterated a Neutral rating on The Clorox Company (NYSE:CLX) on August 04, 2026. Market Context The Clorox Company operates in the Consumer Defensive…
Market Context
The Clorox Company operates in the Consumer Defensive sector. The stock currently trades at $104.67 with a market capitalization of $12.5B. The stock has gained 6.3% over the past 52 weeks.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for The Clorox Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for The Clorox Company
Among the 10 most recent ratings: 0 Buy, 5 Hold, 5 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 04, 2026 | Citigroup | Neutral | N/A |
| Aug 04, 2026 | JP Morgan | Underweight | N/A |
| Aug 04, 2026 | UBS | Neutral | N/A |
| Aug 04, 2026 | Evercore ISI Group | Underperform | N/A |
| Aug 04, 2026 | Wells Fargo | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View CLX Stock Page
Frequently Asked Questions
What does a Neutral rating mean for CLX?
A Neutral rating from UBS reflects the analyst's outlook on The Clorox Company (NYSE:CLX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CLX forecast page.
